Select your Market
Our goal is the elimination of the schistosomiasis disease as a public health problem in line with the World Health Organization (WHO) NTD Roadmap 2021-2030. We are committed to the objectives of the Kigali Declaration on neglected tropical diseases (NTDs), in which participating companies, governments and private organizations commit to helping control and ultimately eliminating the 21 most prevalent NTDs, including schistosomiasis.
…is one of the most devastating tropical disease in terms of public health burden and economic impact. The core objective of our investments in schistosomiasis is to eliminate this life-threatening disease as a public health problem. By providing tablets to treat schistosomiasis at scale, we are enabling people living in highly endemic regions to become healthy and fully active members of their societies. This in turn supports sustainable development in their communities. We are proud to play a part in advancing both stronger health systems and economic growth.
More than 250 million people infected worldwide.
Dive into our initiatives dedicated to eliminating schistosomiasis. Over the past years we have made remarkable progress.